Neuropharmacolgy Flashcards
Bethanechol (Urecholine) mechanism of action
binds to muscarinic cholinergic receptors to relax trigone and sphincter muscles
Bethanechol (Urecholine) adverse effects
hypotension, bradycardia, “see, pee, spit, shit”, N/V/D, increased respiratory secretions and bronchospasm
Bethanechol (Urecholine) nursing considerations
administer on an empty stomach to prevent N/V
assess for gastric obstruction if being used for GI motility issues
monitor for response
admin atropine if OD is suspected
Pilocarpine mechanism of action
binds to muscarinic cholinergic receptors to reduce intraocular pressure and excessive xerostomia
Pilocarpine adverse effects
miosis and blurred vision
sweating
hypotentsion and bradycardia
“see, pee, spit, shit”
syncope, HA, seizure, sweating
inc. respiratory secretions and bronchospasm
Pilocarpine nursing considerations
apply lacrimal pressure for 1-2 minutes post-administration
separate from other opthalamic medications
Pilocarpine patient education
dangers of driving at night and other hazardous occupations with poor illumination
Atropine (AtroPen) mechanism of action
block action of acetylcholine at muscarinic receptors to prevent effects of acetylcholine (primarily heart, exocrine glands, smooth muscles, and eyes)
Atropine (AtroPen) adverse effects
anticholinergic effects (can’t see, can’t pee, can’t spit, can’t sit)
Atropine (AtroPen) nursing considerations
treat OD with symptomatic and supportive therapy
if delirium, hallucinations, or coma occurs administer physostigmine
Oxybutynin (Ditropan XL) mechanism of action
block activation of M3 receptors on the detrusor muscle to cause muscle relaxation
Oxybutynin (Ditropan XL) adverse effects
anticholinergic effects (can’t see, pee, spit, shit)
older adults have higher risk of hallucinations, confusion, and sedation
Oxybutynin (Ditropan XL) nursing considerations
concurrent use with other anticholinergic medications can intensify effects,
monitor mental status closely in older adults
Mirabegron (Myrbetriq) mechanism of action
activates beta-3 receptor to cause detrusor muscle relaxation
Mirabegron (Myrbetriq) adverse effects
angioedema,
dose-related CV effects (HTN, tachycardia, and palpitations),
urinary retention
Pyridostigmine (Mestinon) mechanism of action
prevent breakdown of ACh by AChE via binding to increase amount of ACh available to activate receptors
Pyridostigmine (Mestinon) adverse effects
Excessive muscarinic stimulation: SLUDGE, Killer B’s
neuromuscular blockade
Pyridostigmine (Mestinon) nursing considerations
promote compliance,
assess ability to take PO meds prior to admin
Donepezil (Aricept) mechanism of action
prevents reversible breakdown to ACh by AChE to increase availability of ACh at cholinergic synapses
Donepezil (Aricept) adverse effects
GI effects - N/V/D and dyspepsia
CV effects - symptomatic bradycardia, prolonged QT waves, Torsades de pointes
Donepezil (Aricept) nursing considerations
place patient on fall precautions
monitor CV status and report symptomatic bradycardia and telemetry changes
Donepezil (Aricept) patient education
education on patient and family role in condition management
(this medication is used for AD treatment)
Rivastigmine (Exelon) mechanism of action
prevents irreversible breakdown of ACh by AChE to increase availability of ACh at cholinergic synapses
Rivastigmine (Exelon) adverse effects
GI effects- N/V/D and dyspepsia
CV effects- symptomatic bradycardia
Rivastigmine (Exelon) nursing considerations
place pt on fall precautions
monitor CV status closely and report symptomatic bradycardia
change patch every 24 hours
Rivastigmine (Exelon) patient education
educate pt and family on role in condition management
(this med is used for treatment of AD)
Memantine (Namenda) mechanism of action
modulates the effects of glutamate at NMDA receptors by blocking calcium entry
Memantine (Namenda) adverse effects
generally well tolerated;
CNS effects- dizziness, HA, confusion;
psychometric effects- agitation, delusions, and hallucinations
Memantine (Namenda) nursing considerations
don’t crush or chew ER preparations
monitor cognitive and functional outcomes
Vecuronium (Norcuron) mechanism of action
competitively binds to nitotinic M receptors on the motor end plate to block activation by ACh, causes muscle relaxation and persists as long as medication is sufficient to prevent receptor occupation by ACh
Vecuronium (Norcuron) adverse effects
respiratory arrest and hypotension